Macquarie Group LTD Moderna, Inc. Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 32,708 shares of MRNA stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,708

Previous 42,735 23.46%

Holding current value

$2.15 Million

Previous $4.55 Million 14.69%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$101.21 - $166.61 $1.01 Million - $1.67 Million	-10,027 Reduced 23.46%	32,708 $3.88 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $398,251 - $538,527	4,665 Added 12.25%	42,735 $4.55 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $323,082 - $485,390	4,648 Added 13.91%	38,070 $3.79 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $81,755 - $107,365	-848 Reduced 2.47%	33,422 $3.45 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $68,137 - $92,304	-575 Reduced 1.65%	34,270 $4.16 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $17,093 - $24,824	-126 Reduced 0.36%	34,845 $5.35 Million
Q4 2022 Feb 21, 2023	BUY	$118.38 - $210.04 $2.09 Million - $3.71 Million	17,664 Added 102.06%	34,971 $6.28 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $16,647 - $27,379	-141 Reduced 0.81%	17,307 $2.05 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $44.4 Million - $66.9 Million	-378,931 Reduced 95.6%	17,448 $2.49 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $273,280 - $507,943	-2,161 Reduced 0.54%	396,379 $68.3 Million
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $93.3 Million - $152 Million	-413,013 Reduced 50.89%	398,540 $101 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $156 Million - $341 Million	-702,982 Reduced 46.42%	811,553 $312 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $196 Million - $355 Million	1,509,612 Added 30664.47%	1,514,535 $356 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $88,435 - $150,643	810 Added 19.69%	4,923 $645,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $87,631 - $226,423	1,333 Added 47.95%	4,113 $430,000
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $6,303 - $11,002	116 Added 4.35%	2,780 $197,000
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $79,040 - $213,120	2,664 New	2,664 $171,000

Others Institutions Holding MRNA

# of Institutions

1,112

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Moderna, Inc. Transaction History